Gelteq Limited - Ordinary Shares (GELS)
GELS moved a median of -0.73% 30 minutes after news, and +1.93% by the close. How GELS actually reacts to news — the realized, point-in-time move the market made, measured across 66 labeled events over the last three years with zero look-ahead.
GELS’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 33% | 46 |
| 30-min | -0.73% | 32% | 53 |
| 60-min | -0.33% | 36% | 53 |
| to close | +1.93% | 57% | 54 |
| Middle 50% of GELS reactions | -5.59% to +1.49% |
|---|---|
| Median reaction (30-min) | -0.73% |
| Measured reactions | 66 |
Half of all Gelteq Limited - Ordinary Shares news events land between -5.59% and +1.49% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when GELS moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to GELS's baseline. Nothing else.
Recent GELS events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 6-K Gelteq Ltd For: Jul 02 | SEC filing · Form 6-K | SEC EDGAR | -2.65% | +3.71% | |
| Form 6-K Gelteq Ltd For: Dec 31 | SEC filing · Form 6-K | SEC EDGAR | -1.10% | -6.78% | |
| Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs | Press release | GlobeNewswire | -1.65% | -6.56% | |
| Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications | Press release | GlobeNewswire | +17.30% | +9.99% | |
| Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion | Press release | GlobeNewswire | +0.58% | -0.58% | |
| Form 6-K Gelteq Ltd For: Jun 02 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +1.17% | |
| Form 6-K Gelteq Ltd For: May 26 | SEC filing · Form 6-K | SEC EDGAR | -2.31% | +4.64% | |
| Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway | Press release | GlobeNewswire | — | +16.33% | |
| Healthy Extracts Q1 2026 Net Revenue Up 73% to Record $1.6 Million, Driving Positive EBITDA | Press release | ACCESS Newswire | -2.75% | +2.04% | |
| Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth | Press release | GlobeNewswire | -0.15% | +6.25% | |
| Healthy Extracts Reports Preliminary 2025 Results, Net Revenue Expected Up 45% to Record $4.5 Million | Press release | ACCESS Newswire | +0.00% | -3.00% | |
| Form 6-K Gelteq Ltd For: Mar 24 | SEC filing · Form 6-K | SEC EDGAR | — | +4.00% | |
| Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership | Press release | GlobeNewswire | -2.16% | -2.65% | |
| Gelteq Announces Positive Preclinical Results Showing Increased Medicinal Cannabinoid Absorption Using Its Oral Gel Delivery Platform | Press release | GlobeNewswire | -1.29% | -0.32% | |
| Gelteq Furthers Asia Presence Through Partnership with Hong Kong Flag Football Program | Press release | GlobeNewswire | +0.00% | +1.17% | |
| Form 6-K Gelteq Ltd For: Dec 09 | SEC filing · Form 6-K | SEC EDGAR | -2.58% | -3.45% | |
| Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq’s Nutritional Product Expansion into China | Press release | GlobeNewswire | +4.72% | +5.66% | |
| Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform | Press release | GlobeNewswire | -6.78% | -7.63% | |
| Gelteq to Present at Investor Summit Virtual on December 9, 2025 | Press release | GlobeNewswire | +0.52% | +4.85% | |
| Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform | Press release | GlobeNewswire | +1.58% | -6.20% | |
| Form 20-F Gelteq Ltd For: Jun 30 | SEC filing · Form 20-F | SEC EDGAR | -1.02% | -4.06% | |
| Form NT 20-F Gelteq Ltd For: Jun 30 | SEC filing · Form NT | SEC EDGAR | -0.92% | +0.00% | |
| Gelteq Announces Commencement of Preclinical Trial Targeting Oil Soluble Drug Market with Novel Delivery Platform | Press release | GlobeNewswire | +0.90% | +25.23% | |
| Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compound | Press release | GlobeNewswire | +0.79% | +7.09% | |
| Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner | Press release | GlobeNewswire | -9.91% | -0.62% | |
| Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market | Press release | GlobeNewswire | +26.26% | +57.58% | |
| Healthy Extracts Builds Upon Record Q2 Results and Transformative Merger with Launch of New Revolutionary Hydration and Sugar Metabolism Gel-Packs | Press release | ACCESS Newswire | +0.38% | -16.52% | |
| Form EFFECT Gelteq Ltd | SEC filing · Form EFFECT | SEC EDGAR | +0.00% | -4.00% | |
| Form F-1/A Gelteq Ltd | SEC filing · Form F-1 | SEC EDGAR | +0.00% | +2.14% | |
| Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities | Press release | GlobeNewswire | +0.00% | +10.65% | |
| Form F-1 Gelteq Ltd | SEC filing · Form F-1 | SEC EDGAR | -0.74% | +3.53% | |
| Form 6-K Gelteq Ltd For: Dec 31 | SEC filing · Form 6-K | SEC EDGAR | -0.74% | +3.53% | |
| Gelteq Expands U.S. Operations with Healthy Extracts Inc. as North American Fulfillment Partner | Press release | GlobeNewswire | +5.50% | +47.50% | |
| Form 6-K Gelteq Ltd For: Mar 14 | SEC filing · Form 6-K | SEC EDGAR | — | -9.63% | |
| Gelteq’s Sportsgel Brand Named Official Sponsor of the Professional Pickleball Tour and League of Australia and New Zealand | Press release | GlobeNewswire | +0.00% | +7.06% | |
| Gelteq Launches SportsGel Brand and Signs Distribution Agreement with E-Commerce Solutions Company in Asia-Pacific Region, WPIC | Press release | GlobeNewswire | +1.78% | +2.22% | |
| Gelteq Appoints Matthew Jones as Head of Sports Performance | Press release | GlobeNewswire | -1.11% | +4.44% | |
| Gelteq Appoints Dr. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel Technology | Press release | GlobeNewswire | +3.27% | +12.40% | |
| Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug | Press release | GlobeNewswire | -2.03% | +3.79% | |
| Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor Conference | Press release | GlobeNewswire | +0.48% | +71.15% | |
| Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand | Press release | GlobeNewswire | -2.27% | +73.66% | |
| Gelteq Announces 400,000 Units Enter into Production in November 2024 | Press release | GlobeNewswire | -0.51% | -6.06% | |
| Form 20-F Gelteq Ltd For: Jun 30 | SEC filing · Form 20-F | SEC EDGAR | — | -9.14% | |
| Gelteq Expands Operations in United States with Appointment of Adam Bendell as President of U.S. Operations to Scale Domestic Business | Press release | GlobeNewswire | -4.25% | -4.25% | |
| Form NT 20-F Gelteq Ltd For: Jun 30 | SEC filing · Form NT | SEC EDGAR | +0.00% | -9.82% | |
| Form 6-K Gelteq Ltd For: Oct 30 | SEC filing · Form 6-K | SEC EDGAR | +18.22% | +3.64% | |
| Gelteq Limited Closes US$5.2 Million Initial Public Offering | Press release | GlobeNewswire | +0.04% | -17.84% | |
| Form CERT Gelteq Ltd | SEC filing · Form CERT | SEC EDGAR | -9.34% | -26.50% | |
| Gelteq Limited Prices US$5.2 Million Initial Public Offering | Press release | GlobeNewswire | -9.34% | -26.50% | |
| Form 8-A12B Gelteq Ltd | SEC filing · Form 8-A12B | SEC EDGAR | — | — |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the GELS section they belong to.
Where else GELS is measured.
GELS earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Gelteq Limited - Ordinary Shares's median reaction calculated?
Every labeled GELS news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 66 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 32% of GELS's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does GELS's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.